Maintenance chemotherapy
Showing 9976 - 10000 of >10,000
Advanced NSCLC Trial in La Jolla (Nivolumab, Oxaliplatin, Ipilimumab)
Recruiting
- Advanced NSCLC
- Nivolumab
- +2 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Apr 1, 2021
Pancreatic Cancer Trial in Boston (FOLFIRINOX, Losartan, Proton Beam Radiation)
Unknown status
- Pancreatic Cancer
- FOLFIRINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2020
Cervical Cancer, Chronic Myeloproliferative Disorders, Leukemia Trial in Los Angeles (Fragmin, )
Completed
- Cervical Cancer
- +8 more
- Fragmin
- placebo
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
The mCRC pMMR/MSS or dMMR/MSI-H Status Received Palliative
Completed
- Colorectal Cancer Metastatic
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Jul 23, 2020
Triple Negative Breast Cancer Trial in Tianjin (Camrelizumab, Nab-Paclitaxel, Carboplatin)
Not yet recruiting
- Triple Negative Breast Cancer
- Camrelizumab
- +2 more
-
Tianjin, Tianjin, China
- +1 more
May 25, 2021
Gastric Cancer Trial in Tianjin (Toripalimab, Docetaxel, Fluorouracil)
Recruiting
- Gastric Cancer
- Toripalimab
- +4 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Feb 16, 2021
Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19
Terminated
- Lymphoma, B-Cell
- +3 more
- Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2022
Covid-19 Pandemic on Management of Head and Neck Cancers
Recruiting
- Head and Neck Cancer
- +2 more
-
Amiens, FranceCHU Amiens
Jul 20, 2021
Natural History of Idiopathic CD4+ Lymphocytopenia
Recruiting
- Idiopathic CD4+ Lymphocytopenia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Coagulation Disorder, Carcinomatosis Trial in Sevilla (ROTEM parameters, platelet function assay (PFA-100), von Willebrand and
Completed
- Coagulation Disorder
- Carcinomatosis
- ROTEM parameters, platelet function assay (PFA-100), von Willebrand and Factor XIII
-
Sevilla, Andalucia, SpainHospital Universitario Virgen del Rocio
Mar 8, 2021
Parkinson Disease, Multiple Sclerosis, Stroke Trial in Kansas City (Low-Fidelity PDS, High Fidelity Fixed-Base Simulator)
Recruiting
- Parkinson Disease
- +2 more
- Low-Fidelity PDS
- High Fidelity Fixed-Base Simulator
-
Kansas City, KansasAbiodun Akinwuntan
May 7, 2021
Breast Cancer, Estrogen Receptor-positive Breast Cancer, Metastatic Breast Cancer Trial in Cairo (Capecitabine, Letrozole 2.5mg)
Unknown status
- Breast Cancer
- +2 more
- Capecitabine
- Letrozole 2.5mg
-
Cairo, EgyptFaculty of Medicine, Cairo University
Sep 25, 2020
Breast Cancer, HER2-low-expressing Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Guangzhou (Pyrotinib +
Recruiting
- Breast Cancer
- +3 more
- Pyrotinib + epirubicin and cyclophosphamide followed by docetaxel treatment
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jan 11, 2022
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7 Trial in Bronx, New York
Completed
- Recurrent Renal Cell Carcinoma
- +2 more
- Capecitabine
- +2 more
-
Bronx, New York
- +3 more
Mar 17, 2021
Triple Negative Breast Cancer Trial in Beijing (Epirubicin or Pirarubicin, Cyclophosphamide)
Recruiting
- Triple Negative Breast Cancer
- Epirubicin or Pirarubicin
- Cyclophosphamide
-
Beijing, Beijing, ChinaCancer Hospital & Institute Chinese Academy of Medical Sciences
Jun 16, 2020
Study of Adrenal Gland Tumors
Completed
- Adrenal Gland Neoplasm
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Cancer, Breast Trial in São Paulo (Health Education, Physical Exercise)
Unknown status
- Cancer, Breast
- Health Education
- Physical Exercise
-
São Paulo, BrazilHospital Municipal Vila Santa Catarina
Sep 14, 2020
Melanoma Trial in Stockholm (Cyclophosphamide, Fludarabine, T cells)
Recruiting
- Melanoma
- Cyclophosphamide
- +4 more
-
Stockholm, SwedenKarolinska University Hospital
Sep 17, 2020
Malignant or Benign Pathology Trial in Bordeaux (Airseal®, Standard Insufflation)
Completed
- Malignant or Benign Pathology
- Airseal®
- Standard Insufflation
-
Bordeaux, FranceChu de Bordeaux
Oct 6, 2020
Uveal Melanoma, Liver Metastases Trial in Gothenburg (Isolated hepatic perfusion, Ipilimumab, Nivolumab)
Recruiting
- Uveal Melanoma
- Liver Metastases
- Isolated hepatic perfusion
- +2 more
-
Gothenburg, SwedenSahlgrenska University Hospital
May 3, 2022
Chemo Induced Peripheral Neuropathy Trial in Kowloon Tong (electro-acupuncture)
Completed
- Chemotherapy Induced Peripheral Neuropathy
- electro-acupuncture
-
Kowloon Tong, Kowloon, Hong KongLinda Zhong
Oct 8, 2020
Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma Trial in Los
Withdrawn
- Colorectal Adenocarcinoma
- +7 more
- Guadecitabine
- Nivolumab
-
Los Angeles, California
- +1 more
Apr 1, 2021